1. Panel on opportunistic infections in HIV-infected adults and adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2016.
http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
. Accessed 16 Dec 2016.
2. Kost R, Hill E, Tigges M, Straus S. Recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med. 1993;329:1777–82.
3. Terms, definitions, and calculations used in CDC HIV surveillance publications. Centers for Disease Control and Prevention. 2016.
https://www.cdc.gov/hiv/statistics/surveillance/terms.html
. Accessed 1 May 2017.
4. Strick L, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1—infected persons. Clin Infect Dis. 2006;43:347–56.
5. Freeman E, Weiss H, Glynn J, Cross P, Whitworth J, Hayes R. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83.